Lifecore Biomedical Inc (NASDAQ: LFCR) has recently enjoyed extremely important positive changes in investment behavior: positive upside/downside volume developed, its longer term price trend turned up, and the stock rose on very heavy volume.
Minimal positive changes in fundamentals have recently occurred for Lifecore Biomedical Inc (NASDAQ: LFCR): significant quarterly sales acceleration occurred.
In light of these very positive signals we are reviewing our current Overall Rating of F. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Lifecore Biomedical has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Lifecore Biomedical has a very low Appreciation Score of 1 but a neutral Power Rating of 53, and the Lowest Value Trend Rating results.
Recent Price Action
On 12/31/24, Lifecore Biomedical Inc (NASDAQ: LFCR) stock rose slightly by 0.1%, closing at $7.43. Moreover, exceptionally high trading volume at 365% of normal accompanied the advance. Relative to the market the stock has been strong over the last nine months and has risen 2.6% during the last week.
Be the first to comment